Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Sphingolipid Metabolism and Signaling
TopicLeading institutions, researchers & key papers
This cluster of papers explores the role of sphingolipids, including sphingosine-1-phosphate and ceramide, in signaling and metabolism, with implications for health and disease such as lymphocyte egress, insulin resistance, cancer, and apoptosis.
113
Works
IDs:OpenAlex
How has Sphingolipid Metabolism and Signaling's publication output changed over time?
ScholarIQpublication output · 2001–2020
Output grew0% over the shown period — from 1 works in 2001 to 1 in 2020.
1
1
2
2
1
2
1
2
1
1
2001200320062007201020112013201620172020
What are the most-cited papers on Sphingolipid Metabolism and Signaling?
ScholarIQmost cited works
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
Marcel Verheij, Ron Bose, Xin Lin, Bei Yao, W. David Jarvis, Steven Grant, Michael J. Birrer, Éva Szabó, Leonard I. Zon, John Kyriakis, Adriana Haimovitz‐Friedman, Zvi Fuks, Richard Kolesnick
Nature. 19961,796 Citations
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
Reijo Laaksonen, Kim Ekroos, Marko Sysi‐Aho, Mika Hilvo, Terhi Vihervaara, Dimple Kauhanen, Matti Suoniemi, Reini Hurme, Winfried März, Hubert Scharnagl, Tatjana Stojaković, Efthymia Vlachopoulou, Marja‐Liisa Lokki, Markku S. Nieminen, Roland Klingenberg, Christian M. Matter, Thorsten Hornemann, Peter Jüni, Nicolas Rodondi, Lorenz Räber, Stephan Windecker, Bariş Gencer, Eva Ringdal Pedersen, Grethe S. Tell, Ottar Nygård, François Mach, Juha Sinisalo, Thomas F. Lüscher
European Heart Journal. 2016690 CitationsOPEN ACCESS
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
Fred Lublin, David H. Miller, Mark S. Freedman, Bruce Cree, Jerry S. Wolinsky, Howard L. Weiner, Catherine Lubetzki, Hans‐Peter Hartung, Xavier Montalbán, Bernard M.J. Uitdehaag, Martin Merschhemke, Bingbing Li, Norman Putzki, Fonda Liu, Dieter A. Häring, Ludwig Kappos
The Lancet. 2016452 CitationsOPEN ACCESS
Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevención con Dieta Mediterránea)
Dong D. Wang, Estefanía Toledo, Adela Hruby, Bernard Rosner, Walter C. Willett, Qi Sun, Cristina Razquín, Yan Zheng, Miguel Ruiz‐Canela, Marta Guasch‐Ferré, Dolores Corella, Enrique Gómez‐Gracia, Miquel Fiol, Ramón Estruch, Emilio Ros, José Lapetra, Montserrat Fitó, Fernando Arós, Luís Serra‐Majem, Chih‐Hao Lee, Clary B. Clish, Liming Liang, Jordi Salas‐Salvadó, Miguel Ángel Martínez‐González, Frank B. Hu
Circulation. 2017330 CitationsOPEN ACCESS
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
Eugen Ruckhäberle, Achim Rody, Knut Engels, R. Gaetje, Gϋnter von Minckwitz, Susanne Schiffmann, Sabine Grösch, Gerd Geißlinger, Uwe Holtrich, Thomas Karn, Manfred Kaufmann
Breast Cancer Research and Treatment. 2007297 Citations
Where is Sphingolipid Metabolism and Signaling research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Sphingolipid Metabolism and Signaling is open access?
ScholarIQopen access share
73%OPEN ACCESS
Gold
7%
Green
40%
Hybrid
20%
Bronze
7%
Closed
27%
Related on ScholarIQ
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
Paper
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Paper
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Paper
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
Paper
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Paper
Insulin-stimulated Activation of eNOS Is Independent of Ca2+ but Requires Phosphorylation by Akt at Ser1179
Paper